KEI ITAGAKI

Last Updated :2023/02/02

Affiliations, Positions
Hiroshima University Hospital(Medical), Assistant Professor
E-mail
itagakikhiroshima-u.ac.jp
Self-introduction
I am working on the development of objective evaluation methods for diagnosis and therapeutic effects, focusing on mood disorders.

Basic Information

Academic Degrees

  • Hiroshima University

Research Fields

  • Medicine,dentistry, and pharmacy;Clinical internal medicine;Psychiatric science

Educational Activity

Course in Charge

  1. 2022, Undergraduate Education, Year, Medical Neuroscience III
  2. 2022, Undergraduate Education, Intensive, Practice of Medicine I
  3. 2022, Undergraduate Education, 1Term, Psychiatry
  4. 2022, Undergraduate Education, 1Term, Psychiatry

Research Activities

Academic Papers

  1. Altered Serum Levels of Matrix Metalloproteinase-2, -9 in Response to Electroconvulsive Therapy for Mood Disorders, Int J Neuropsychopharmacol, 19(9), 2016
  2. ★, Factors Associated With Relapse After a Response to Electroconvulsive Therapy in Unipolar Versus Bipolar Depression, Journal of Affective Disorders, 208, 113-119, 2017
  3. Decreased serum levels of thrombospondin-1 in female depressed patients, Neuropsychopharmacol Rep, 40(1), 39-45, 2019
  4. ★, Reduced Serum and Cerebrospinal Fluid Levels of Autotaxin in Major Depressive Disorder, International Journal of Neuropsychopharmacology, 22(4), 261-269, 2019
  5. The expression of glial cell line-derived neurotrophic factor mRNA by antidepressants involves matrix metalloproteinase-9 activation in rat astroglial cells, Biochem Biophys Res Commun, 28;479(4), 907-912, 2016
  6. Identification of Lysophosphatidic Acid Receptor 1 in Astroglial Cells as a Target for Glial Cell Line-derived Neurotrophic Factor Expression Induced by Antidepressants, J Biol Chem, 30;291(53), 27364-27370, 2019
  7. Possible Association between Serum Matrix Metalloproteinase-9 (MMP-9) Levels and Relapse in Depressed Patients following Electroconvulsive Therapy (ECT), Int J Neuropsychopharmacol, 1;21(3), 236-241, 2018
  8. Shared preventive factors associated with relapse after a response to electroconvulsive therapy in four major psychiatric disorders, Psychiatry Clin Neurosci, 73(8), 494-500, 2019